Company: ASB
Filing Date: 2025-12-30
Form Type: S-4
Source: 0001193125-25-337086
Chunk: 43

Company: ASSOCIATED BANC-CORP
Filing Date: 2025-12-30
Form: S-4
Chunk 43
---
 review of the Merger to analyze the Merger’s
competitive effects and determine whether the Merger would result in a violation of the antitrust laws. Transactions approved under section 3 of the BHC Act generally may not be completed until 30 days after the approval of the applicable
federal agency is received, during which time the DOJ may challenge the Merger on antitrust grounds. With the approval of the applicable federal agency and the concurrence of the DOJ, the waiting period may be reduced to no less than 15 days. The
commencement of an antitrust action would stay the effectiveness of such an approval unless a court specifically ordered otherwise.

In
reviewing the Merger, the DOJ could analyze the Merger’s effect on competition differently than the Federal Reserve Board, and, thus, it is possible that the DOJ could reach a different conclusion than the Federal Reserve Board regarding the
Merger’s effects on competition. A determination by the DOJ not to object to the Merger may not prevent the filing of antitrust actions by private persons or state attorneys general. There can be no assurance that the DOJ, private persons or
state attorneys general will not challenge the Merger.

Additional Regulatory Approvals and Notices

Additional notifications and/or applications requesting approval may be submitted to various other federal, state and non-U.S. regulatory authorities and self-regulatory organizations.

Listing of Associated Common Stock

Associated common stock is listed for trading on the NYSE under the symbol “ASB.” Under the terms of the
Merger Agreement, Associated will cause the shares of Associated common stock to be issued in the Merger to be approved for listing on the NYSE, subject to official notice of issuance, prior to the effective time. The

31

Merger Agreement provides that neither Associated nor American National will be required to complete the Merger if such shares are not authorized for listing on the NYSE, subject to official
notice of issuance. Following the Merger, shares of Associated common stock will continue to be listed on the NYSE.

No Dissenters’ or Appraisal Rights in the Merger

American National shareholders are not entitled to any dissenters’ or
appraisal rights in connection with the Merger.

32

THE MERGER AGREEMENT

This section of the information statement/prospectus describes the material terms of the Merger Agreement. The description in this section and elsewhere in this information statement/prospectus is subject to and qualified in its entirety by reference to the complete text of the Merger Agreement